Canopy Growth (CGC) Competitors $1.50 +0.11 (+7.55%) As of 10:03 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CGC vs. ACB, CRON, OGI, SNDL, TLRY, VFF, STZ, AVDL, SDGR, and GPCRShould you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Constellation Brands (STZ), Avadel Pharmaceuticals (AVDL), Schrodinger (SDGR), and Structure Therapeutics (GPCR). Canopy Growth vs. Its Competitors Aurora Cannabis Cronos Group Organigram Global SNDL Tilray Brands Village Farms International Constellation Brands Avadel Pharmaceuticals Schrodinger Structure Therapeutics Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership. Do insiders & institutionals have more ownership in ACB or CGC? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 0.2% of Canopy Growth shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts prefer ACB or CGC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.60Canopy Growth 3 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.25 Which has preferable earnings & valuation, ACB or CGC? Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$357.88M0.96$1.63M-$0.19-32.17Canopy Growth$274.92M1.30-$429.86M-$3.03-0.49 Which has more risk and volatility, ACB or CGC? Aurora Cannabis has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Is ACB or CGC more profitable? Aurora Cannabis has a net margin of -5.66% compared to Canopy Growth's net margin of -155.76%. Aurora Cannabis' return on equity of -1.49% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-5.66% -1.49% -1.06% Canopy Growth -155.76%-89.93%-44.24% Does the media prefer ACB or CGC? In the previous week, Canopy Growth had 8 more articles in the media than Aurora Cannabis. MarketBeat recorded 10 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.89 beat Canopy Growth's score of 0.74 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAurora Cannabis beats Canopy Growth on 12 of the 16 factors compared between the two stocks. Get Canopy Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGC vs. The Competition Export to ExcelMetricCanopy GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$356.18M$10.67B$6.13B$10.63BDividend YieldN/A1.86%5.51%4.67%P/E Ratio-0.4922.3186.0727.10Price / Sales1.3027.55587.32183.34Price / CashN/A25.6126.3031.10Price / Book0.793.4713.096.71Net Income-$429.86M$210.63M$3.30B$276.23M7 Day Performance2.40%2.96%5.49%4.30%1 Month Performance2.40%2.51%9.27%11.61%1 Year Performance-64.40%-4.87%86.14%41.42% Canopy Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGCCanopy Growth0.7423 of 5 stars$1.50+7.6%N/A-68.6%$356.18M$274.92M-0.493,150ACBAurora Cannabis0.4596 of 5 stars$6.23+28.2%N/A+5.6%$350.25M$246.72M-32.791,130High Trading VolumeCRONCronos Group1.5556 of 5 stars$2.97+12.9%N/A+13.8%$1.14B$117.61M59.40450High Trading VolumeOGIOrganigram Global1.0557 of 5 stars$1.97+16.6%N/A+5.1%$264.65M$117.47M39.41860High Trading VolumeSNDLSNDL3.2214 of 5 stars$2.74+17.6%$4.50+64.2%+28.0%$720.02M$671.81M-10.152,516Analyst DowngradeHigh Trading VolumeTLRYTilray Brands2.949 of 5 stars$1.85+60.9%$1.94+4.7%-6.5%$2.04B$821.31M-0.802,842Upcoming EarningsHigh Trading VolumeVFFVillage Farms International1.0748 of 5 stars$3.33+26.1%N/A+263.3%$375.09M$336.18M37.001,400High Trading VolumeSTZConstellation Brands4.5675 of 5 stars$136.37+2.9%$191.28+40.3%-43.7%$24.04B$10.96B-57.0610,600Trending NewsEarnings ReportDividend AnnouncementAVDLAvadel Pharmaceuticals3.0874 of 5 stars$15.31-0.2%$20.86+36.2%+11.0%$1.49B$169.12M-510.3370Positive NewsSDGRSchrodinger3.3541 of 5 stars$20.04+3.8%$27.83+38.9%+21.6%$1.48B$207.54M-8.08790Analyst DowngradeGPCRStructure Therapeutics3.12 of 5 stars$25.30+1.2%$68.67+171.4%-33.3%$1.46BN/A-24.10136 Related Companies and Tools Related Companies ACB Competitors CRON Competitors OGI Competitors SNDL Competitors TLRY Competitors VFF Competitors STZ Competitors AVDL Competitors SDGR Competitors GPCR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGC) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Canopy Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
